Stock DANCAN DANCANN PHARMA A/S
Add to a list
To use this feature you must be a member
Log inSign up

All News Dancann Pharma A/S

Equities

DANCAN

DK0061410487

End-of-day quote NORDIC GROWTH MARKET
Other stock markets
 06:00:00 2024-04-23 pm EDT 		5-day change 1st Jan Change
0.065 DKK +22.64% Intraday chart for Dancann Pharma A/S +164.23% +116.67%
Mar. 29 Dancann Pharma Plans Up to DKK19 Million Rights Issue MT
Feb. 28 DanCann Pharma Notes Cannabis Legalization in Germany as Shares Surge MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
DanCann Pharma A/S: MINUTES OF EXTRAORDINARY GENERAL MEETING
AQ
NOTICE OF EXTRAORDINARY GENERAL MEETING IN DANCANN PHARMA A/S
AQ
Dancann Pharma Plans Up to DKK19 Million Rights Issue
MT
DanCann Pharma A/S intends to initiate and complete a partly secured rights issue of up to DKK 18.5 million to restructure, strengthen and secure a debt-free capital structure
AQ
DanCann Pharma Notes Cannabis Legalization in Germany as Shares Surge
MT
DanCann Pharma A/S: Germany makes historic move towards cannabis reclassification and legalization
AQ
DanCann Pharma A/S Reports Fourth Quarter and Full Year 2023 Results
AQ
Dancann Pharma A/S Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Dancann Pharma A/S Reports Earnings Results for the Full Year Ended December 31, 2023
CI
DanCann Pharma A/S Completes Issuance (8) of New Shares from Debt Conversion under the 10-Year Financing Loan-Agreement with 12-months Conversion Option with Nordic Growth Opportunities 2
AQ
DanCann Pharma A/S delivers annual shareholder letter and investor update
AQ
Dancann Pharma A/S Provides Revenue Guidance for the Financial Year 2025
CI
DanCann Pharma A/S: Flagging announcement
AQ
DanCann Pharma A/S publishes Q3-2023 report
AQ
Dancann Pharma A/S Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
DanCann Pharma A/S Completes Issuance (7) of New Shares under the Loan-Agreement with Nordic Growth Opportunities 2 - Marking a Milestone with a Conversion Rate Exceeding 50 percent of Tranche 1
AQ
DanCann Pharma Issues New Shares For Debt Conversion
MT
DanCann Pharma A/S Completes Issuance (6) of New Shares from Debt Conversion under the 10-Year Financing Loan-Agreement with 12-months Conversion Option with Nordic Growth Opportunities 2
AQ
DanCann Pharma A/S: Future strategic direction
AQ
DanCann Pharma Issues New Shares Following Debt Conversion
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. DANCAN Stock
  4. News Dancann Pharma A/S